The Resynchronization–Defibrillation for Ambulatory Heart Failure Trial (RAFT) showed a greater benefit with respect to mortality at 5 years among patients who received cardiac-resynchronization ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results